LIFETECH SCI.DL-00000125

Research LIFETECH SCI.DL-00000125 (81X) on Bullrun: market cap EUR 611.71M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 611.71M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 1.37BCNY 147.83MCNY 399.03M74.4%0.03CNY 719.32MCNY 8.04MCNY 3.51B
FY2024CNY 1.30BCNY 222.39MCNY 38.46M75.3%0.05CNY 665.76MCNY 4.98MCNY 3.49B
FY2023CNY 1.27BCNY 263.24MCNY 125.36M78.6%0.06CNY 979.31MCNY 9.30MCNY 3.37B
FY2022CNY 1.10BCNY 325.34MCNY 52.85M79.6%0.07CNY 833.79MCNY 9.67MCNY 2.90B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 611.71Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About LIFETECH SCI.DL-00000125

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is LIFETECH SCI.DL-00000125's market cap?

LIFETECH SCI.DL-00000125's market capitalization is EUR 611.71M.

What does LIFETECH SCI.DL-00000125 do?

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments.